Michael R. Tota - Concepedia

Author

Michael R. Tota

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

M R Tota, M Tota, M. R. Tota, M. Tota, M.R. Tota, Michael R Tota, Michael R. Tota, Michael Tota

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Oregon State University Rosetta Stone (United States)University of Washington

About

Michael R. Tota is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.9K
2	Natural Sciences	7	7	745
3	Health Sciences	3	3	274
4	Public Health	2	2	224
5	Social Sciences	1	1	298

Michael R. Tota

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
The family of G‐protein‐coupled receptors Catherine D. Strader, Tung M. Fong, Michael P. Grazlano, The FASEB Journal Molecular BiologyMolecular PharmacologyLarge FamilyG‐protein‐coupled ReceptorsReceptor Activation	1995	374
A role for the melanocortin 4 receptor in sexual function Lex H.T. Van der Ploeg, William J. Martin, Andrew D. Howard, Proceedings of the National Academy of Sciences Erectile DysfunctionFood IntakeReproductive BiologySocial SciencesHypothalamic Peptide	2002	298
ART (Protein Product of Agouti-Related Transcript) as an Antagonist of MC-3 and MC-4 Receptors Tung M. Fong, Cheri Mao, Tanya MacNeil, Biochemical and Biophysical Research Communications Signal TransductionMolecular PhysiologyG Protein-coupled ReceptorMedicineFunctional Selectivity	1997	218
Molecular Determinants of Ligand Binding to the Human Melanocortin-4 Receptor Yingkui Yang, Tung M. Fong, Chris J. Dickinson, Biochemistry	2000	173
Liver and Adipose Expression Associated SNPs Are Enriched for Association to Type 2 Diabetes Hua Zhong, John Beaulaurier, Pek Yee Lum, PLoS Genetics GeneticsGenetic EpidemiologyHuman PolymorphismPathologySingle Snps	2010	172
Localization of Leptin Binding Domain in the Leptin Receptor Tung M. Fong, Ruey-Ruey C. Huang, Michael R. Tota, Molecular Pharmacology	1998	149
Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes Margaret Wu, Sheo B. Singh, Jun Wang, Proceedings of the National Academy of Sciences Fatty Acid SynthaseInsulin SignalingDb/db MiceMetabolic SyndromeMouse Models	2011	145
Functional STAT 1 and 3 signaling by the leptin receptor (OB-R); reduced expression of the rat fatty leptin receptor in transfected cells. Charles Rosenblum, Michael R. Tota, Doris Cully, Endocrinology ImmunologyStat Signal TransductionAdipokinesGastrointestinal Peptide HormoneInflammation	1996	119
Crystal Structure of Human Phosphodiesterase 3B: Atomic Basis for Substrate and Inhibitor Specificity Giovanna Scapin, Sangita B. Patel, Jeffrey P. Varnerin, Biochemistry Crystal StructureProteinlipid InteractionMolecular BiologyChemical BiologyMetabolic Syndrome	2004	116
Characterization of the binding domain of the beta-adrenergic receptor with the fluorescent antagonist carazolol. Evidence for a buried ligand binding site. Michael R. Tota, Catherine D. Strader Journal of Biological Chemistry	1990	100

Page 1